| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/14/2002 | CA2422506A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 03/14/2002 | CA2422204A1 Human antibodies against pseudomonas aeruginosa lps derived from transgenic mice |
| 03/14/2002 | CA2422200A1 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
| 03/14/2002 | CA2421451A1 Method and system for myocardial infarction repair |
| 03/14/2002 | CA2421445A1 Hla binding peptides and their uses |
| 03/14/2002 | CA2421409A1 Use of lipopeptides for immunotherapy of hiv-positive subjects |
| 03/14/2002 | CA2421374A1 Methods and compositions for diseases associated with amyloidosis |
| 03/14/2002 | CA2421199A1 Hiv regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
| 03/14/2002 | CA2421193A1 Hiv peptides, antigens, vaccine compositions,immunoassay kit and a method of detecting antibodies induced by hiv |
| 03/14/2002 | CA2421179A1 Acid-sensitive compounds, preparation and uses thereof |
| 03/14/2002 | CA2421067A1 Adenosine derivatives and use thereof |
| 03/14/2002 | CA2421018A1 Dihydroxy open-acid salt of simvastatin |
| 03/14/2002 | CA2419681A1 Switchable tackiness coating compositions for ophthalmic implants |
| 03/14/2002 | CA2419456A1 Methods and compositions for producing a neurosalutary effect in a subject |
| 03/14/2002 | CA2417258A1 Flavoring systems for pharmaceutical compositions and methods of making such compositions |
| 03/14/2002 | CA2389739A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same |
| 03/13/2002 | EP1186626A1 Composition for soluble films with a new hydrolyzed polysaccharide |
| 03/13/2002 | EP1186602A2 Omeprazole sodium salt and its use as anti-ulcer agent |
| 03/13/2002 | EP1186302A1 Ocular tension lowering composition for topical adminstration |
| 03/13/2002 | EP1186298A2 Structures and methods for administering cannabis to patients |
| 03/13/2002 | EP1186293A2 Intermittent administration of a growth hormone secretagogue |
| 03/13/2002 | EP1186292A2 Solid composition with a multi-core structure |
| 03/13/2002 | EP1186290A2 Method and device for treating scars |
| 03/13/2002 | EP1185674A1 Cationic lipids for gene transfer and preparation method thereof |
| 03/13/2002 | EP1185659A2 Dna pcv vaccine |
| 03/13/2002 | EP1185618A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
| 03/13/2002 | EP1185558A1 Peptide having preptin functionality |
| 03/13/2002 | EP1185551A1 Method for purification of proteins |
| 03/13/2002 | EP1185540A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 03/13/2002 | EP1185316A1 Devices and compounds for treating arterial restenosis |
| 03/13/2002 | EP1185309A1 Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 03/13/2002 | EP1185304A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 03/13/2002 | EP1185301A1 Emulsion vehicle for poorly soluble drugs |
| 03/13/2002 | EP1185294A2 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 03/13/2002 | EP1185288A1 Hemoactive compositions and methods for their manufacture and use |
| 03/13/2002 | EP1185278A1 Fibrin polymer structure |
| 03/13/2002 | EP1185274A1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
| 03/13/2002 | EP1185273A1 Antifungal oral composition containing itraconazole and process for preparing same |
| 03/13/2002 | EP1185256A1 Utilization of a highly fluorinated oligomeric alkan in ophthalmology |
| 03/13/2002 | EP1185254A2 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 03/13/2002 | EP1185253A2 Oral administration form for administering a fixed tramadol and diclofenac combination |
| 03/13/2002 | EP1185252A1 Novel formulations comprising lipid-regulating agents |
| 03/13/2002 | EP1185251A1 A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the same |
| 03/13/2002 | EP1185250A2 Enteric coated pharmaceutical formulation |
| 03/13/2002 | EP1185249A2 Methods and compositions for treating solid tumors |
| 03/13/2002 | EP1185248A2 Supercritical fluid-assisted nebulization and bubble drying |
| 03/13/2002 | EP1185247A1 Anti-inflammatory bioactive glass particulates |
| 03/13/2002 | EP1185246A1 Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water |
| 03/13/2002 | EP1185171A1 Compositions and methods comprising morphine gluconate |
| 03/13/2002 | EP1109535A4 Extended release acetaminophen |
| 03/13/2002 | EP0944384B1 Transdermal drug delivery system for the treatment of heart diseases |
| 03/13/2002 | EP0934056B1 Cleansing products |
| 03/13/2002 | EP0859623B1 Absorbable prophylactic composition for protection against ionising or non-ionising electromagnetic waves |
| 03/13/2002 | EP0833573B1 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals |
| 03/13/2002 | EP0724885B1 Pernasal composition and pernasal preparation containing the same |
| 03/13/2002 | EP0652757B1 Sugar-free dry mix cellulose ether compositions as bulk laxatives |
| 03/13/2002 | EP0647144B1 Vaginal discharge collection and drug delivery device |
| 03/13/2002 | CN2481311Y Wound adhesive dressing |
| 03/13/2002 | CN1340098A Astrocytes, their preparation and use thereof |
| 03/13/2002 | CN1340079A Freeze-dried agent containing paramylon, production and utilization thereof |
| 03/13/2002 | CN1340055A Shortened-chain polynucleotide and process for the preparation thereof |
| 03/13/2002 | CN1339976A Implant article |
| 03/13/2002 | CN1339973A Gene therapy for diabetic ischemic disease |
| 03/13/2002 | CN1339972A Tablets quickly disintegrated in the oral cavity |
| 03/13/2002 | CN1339971A Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 03/13/2002 | CN1339969A Liposone composition and method for administration of a radiosensitizer |
| 03/13/2002 | CN1339965A Combinations of formoterol and fluticasone propionate for asthma |
| 03/13/2002 | CN1339964A Biodegradable composite material for the production of microcapsules |
| 03/13/2002 | CN1339963A Spontaneously dispersible N-benzoyl staurosporine compositions |
| 03/13/2002 | CN1339962A Stable non-aqueous single phase viscons vehicles and formulations utilizing such vehicles |
| 03/13/2002 | CN1339955A Gels formed by the interaction of poly(aldehyde) with various sabstances |
| 03/13/2002 | CN1339944A Organoprotective solutions |
| 03/13/2002 | CN1339314A Processing method of medicinal powder for diabetes |
| 03/13/2002 | CN1339312A Wound plaster of yannan Baiyao and its preparing method |
| 03/13/2002 | CN1339310A Shaddock-lozenge tablet and its producing method |
| 03/13/2002 | CN1339309A Preparing process for haw and ginkgo leaf capsule |
| 03/13/2002 | CN1339306A Gastric ulcer ointment |
| 03/13/2002 | CN1339299A Method for preparing medicine for urogenital system |
| 03/13/2002 | CN1339297A New medicine release system-liposolubility medicinal preparation |
| 03/13/2002 | CN1080572C Pain stopping ointment for curing rhrumetism and hyperplasia and its preparing process |
| 03/13/2002 | CN1080569C Prescription of Yizhifutanwan for reinforcing wisdom and rehabilitating paralysis |
| 03/13/2002 | CN1080565C External-use capsule for curing woman diseases |
| 03/13/2002 | CN1080563C Use of sunflower stalk core as medicinal preparation for treating cancer |
| 03/13/2002 | CN1080561C Anti-inflammatory agent for external use |
| 03/13/2002 | CN1080560C Oral medicinal liquor for abstaining from taking drug and production technology thereof |
| 03/13/2002 | CN1080559C Method of production of sustained-release preparation |
| 03/12/2002 | US6355752 Water soluble and swellable; cosmetic thickeners |
| 03/12/2002 | US6355693 Solvent extraction; mixing with alcohol; desolventizing |
| 03/12/2002 | US6355684 Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 03/12/2002 | US6355676 Skin disorders; antiarthritic agents |
| 03/12/2002 | US6355622 Use of a melanoma differentiation associated gene (mda-7) for inducing apoptosis of a tumor cell |
| 03/12/2002 | US6355611 Salt form of a conjugate useful in the treatment of prostate cancer |
| 03/12/2002 | US6355609 Methods for stabilizing liquid nutritional products and products so stabilized |
| 03/12/2002 | US6355280 For inhibiting cellular aging and for protection of the skin against negative environmental factors and pollutants |
| 03/12/2002 | US6355276 Adhesive drug delivery composition |
| 03/12/2002 | US6355275 Delivering an embolic agent formulation to a blood vessel to fill or plug the blood vessel and/or encourage clot formation so that blood flow through the vessel is reduced or ceases |
| 03/12/2002 | US6355274 Encapsulated long chain alcohols |
| 03/12/2002 | US6355273 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization |
| 03/12/2002 | US6355272 Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharamaceutical compositions |
| 03/12/2002 | US6355271 Mixing an aqueous solution of calcium chloride with an aqueous solution of sodium citrate to form a mixture, adding an aqueous solution of sodium phosphate to the mixture to form a solution, stirring the solution |